167 related articles for article (PubMed ID: 33519233)
1. Effect of Simultaneous Integrated Boost Intensity Modulated Radiation Therapy (SIB-IMRT) and Non-Operative Strategy on Outcomes of Distal Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node.
Li S; Geng J; Wang L; Teng H; Wang Z; Zhu X; Zhang Y; Wang H; Li Y; Cai Y; Wu A; Wang W
Cancer Manag Res; 2021; 13():537-546. PubMed ID: 33519233
[TBL] [Abstract][Full Text] [Related]
2. Preliminary results of simultaneous integrated boost intensity-modulated radiation therapy based neoadjuvant chemoradiotherapy on locally advanced rectal cancer with clinically suspected positive lateral pelvic lymph nodes.
Geng JH; Zhang YZ; Li YH; Li S; Wang L; Wang ZL; Zhu XG; Bu ZD; Li ZY; Su XQ; Cai Y; Wu AW; Wang WH
Ann Transl Med; 2021 Feb; 9(3):217. PubMed ID: 33708844
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients With Clinically Positive Lateral Pelvic Lymph Node.
Li S; Zhang Y; Yu Y; Zhu X; Geng J; Teng H; Wang Z; Sun T; Wang L; Wang H; Li Y; Wu A; Cai Y; Wang W
Front Oncol; 2020; 10():627572. PubMed ID: 33692945
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Intensified Chemoradiation with Intensity-Modulated Radiotherapy and Simultaneous Integrated Boost Combined with Capecitabine in Locally Advanced Rectal Cancer: Long-Term Outcomes of a Real-Life Multicenter Study.
Lupattelli M; Palazzari E; Polesel J; Chiloiro G; Angelicone I; Panni V; Caravatta L; Di Biase S; Macchia G; Niespolo RM; Franco P; Epifani V; Meldolesi E; de Giacomo F; Lucarelli M; Montesi G; Mantello G; Innocente R; Osti MF; Gambacorta MA; Aristei C; De Paoli A
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067405
[TBL] [Abstract][Full Text] [Related]
5. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
6. Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer.
Dharmarajan S; Shuai D; Fajardo AD; Birnbaum EH; Hunt SR; Mutch MG; Fleshman JW; Lin AY
J Gastrointest Surg; 2011 Aug; 15(8):1368-74. PubMed ID: 21533959
[TBL] [Abstract][Full Text] [Related]
7. Lateral Pelvic Nodal Management and Patterns of Failure in Patients Receiving Short-Course Radiation for Locally Advanced Rectal Cancer.
Hassanzadeh C; Mirza K; Kalaghchi B; Fallahian F; Chin RI; Roy A; Stowe H; Low G; Pedersen K; Wise P; Glasgow S; Roach M; Henke L; Badiyan S; Mutch M; Kim H
Dis Colon Rectum; 2024 Jan; 67(1):54-61. PubMed ID: 37787502
[TBL] [Abstract][Full Text] [Related]
8. Is neoadjuvant chemoradiotherapy sufficient in patients with advanced rectal malignancy and positive extra-mesorectal lateral lymph nodes?
Ahmadi N; Brown KGM; Lee P; Quinn M; Austin KKS; Solomon MJ
Colorectal Dis; 2020 Jun; 22(6):689-693. PubMed ID: 31909851
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
[No Abstract] [Full Text] [Related]
10. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study.
Lan W; Lihong L; Chun H; Shutang L; Qi W; Liang X; Xiaoning L; Likun L
Strahlenther Onkol; 2022 Sep; 198(9):802-811. PubMed ID: 35029718
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the therapeutic effect of synchronous integrated intensity modulated radiotherapy combined with chemotherapy in stage IIIc of cervical cancer.
Mu Y; Wang H; Xu L; Shi L; Song R; Wang D; Gao Y; Yan H
Front Oncol; 2024; 14():1283991. PubMed ID: 38884092
[TBL] [Abstract][Full Text] [Related]
13. The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes.
Meldolesi E; Chiloiro G; Giannini R; Menghi R; Persiani R; Corvari B; Coco C; Manfrida S; Ratto C; De Luca V; Sofo L; Reina S; Crucitti A; Masiello V; Dinapoli N; Valentini V; Gambacorta MA
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406415
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer After Total Neoadjuvant Therapy (TNT).
Peacock O; Manisundaram N; Dibrito SR; Kim Y; Hu CY; Bednarski BK; Konishi T; Stanietzky N; Vikram R; Kaur H; Taggart MW; Dasari A; Holliday EB; You YN; Chang GJ
Ann Surg; 2022 Oct; 276(4):654-664. PubMed ID: 35837891
[TBL] [Abstract][Full Text] [Related]
15. [Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy].
Li SJ; Wang L; Zhang XY; Li YH; Li ZW; Wu Q; Sun YS; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):648-655. PubMed ID: 31302963
[No Abstract] [Full Text] [Related]
16. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
Li XA; Wang JZ; Jursinic PA; Lawton CA; Wang D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1251-7. PubMed ID: 15752907
[TBL] [Abstract][Full Text] [Related]
18. Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.
Sekido Y; Nishimura J; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Haraguchi N; Hata T; Matsuda C; Mizushima T; Murata K; Hasegawa J; Mori M; Doki Y
Surg Today; 2020 Mar; 50(3):292-297. PubMed ID: 31595366
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal Cancer.
Innocente R; Navarria F; Petri R; Palazzari E; Vecchiato M; Polesel J; Ziccarelli A; Martino A; Ubiali P; Tonin D; Lauretta A; Belluco C; Foltran L; Buonadonna A; Lleshi A; Colombo CB; Barresi L; Gigante M; Franchin G; De Paoli A
Front Oncol; 2021; 11():626275. PubMed ID: 33680967
[TBL] [Abstract][Full Text] [Related]
20. A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.
Gao LR; Wang X; Han W; Deng W; Li C; Wang X; Zhao Y; Ni W; Chang X; Zhou Z; Deng L; Wang W; Liu W; Liang J; Zhang T; Bi N; Wang J; Zhai Y; Feng Q; Lv J; Li L; Xiao Z
BMC Cancer; 2020 Sep; 20(1):901. PubMed ID: 32962674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
